All Type of News
Rude multinational companies, causing defect & out-of-stock issues
Even if it has happened for a while, a lot of complaints have still been created on multinational pharmaceutical companies’ high-handed behaviors.
The pharmaceutical circles raised voices that there has been no promp...
National Pension Service makes losses over Hanmi Pharm’s delayed notification
Assemblyperson Seok-Jin Kang from the Saenuri Party raised a possibility of unfair trade regarding losses on selling Hanmi Pharm’s short stocks.
At the National Assembly for the National Pension Service on the 10th, ...
“NPS should file for damage claims if finding Hanmi’s illegal activities”
While the Hanmi Pharm’s delayed report about patient side effects has aroused various doubts, a suggestion was made if the National Pension Service should file a damage claim for estimated losses of KRW 150 billion on...
Ildong Pharmaceutical selected for probiotics-related national projectsIldong Pharmaceutical(CEO Woong-Sup Yoon) was selected for national projects related to probiotics by the government.
Ildong Pharmaceutical announced it will exercise the Minis...
|
What are reasons why Pfizer spend energies on ‘Centrum’ marketing?Recently, Pfizer Pharmaceuticals Korea has given its best on promoting the top 2nd product in the Korean vitamins market, ‘Centrum.’ It means the company will target OTC drugs a...
|
Which are multinational pharmas actively making joint researches with Korea?
Which are multinational pharmaceutical companies that are active on joint researches and developments with Korean medical institutes and hospitals?
According to the KRPIA Research Report published by the Korean Resea...
Pharmaceutical wholesalers to enlarge new dist. channels with convenience and H&B stores
Pharmaceutical distribution companies started to focus on building new distribution channels to strengthen values of products they distribute.
According to the distribution industry, sales of emergency household drug...
Multinational pharma raises controversy over obligation of
Pharmaceutical distribution companies raise complaints over a multinational company which has established agreements with unfair terms and conditions, such as obligation of ordering inventories for 3 months.
Unlike ...
Listed pharmas’ stock prices dropped by 17% after Hanmi incident
Stock prices of listed pharmaceutical companies collapsed by 17% after the Hanmi Pharm crisis.
Moreover, approximately KRW 9 trillion was studied to evaporate from these listed pharmas’ market capitalization by the ...
Hanmi, “Olmutinib in progress, Phase 3 plan temporarily suspended”When it comes to the ‘the300’s(Money Today)’ article ‘Boehringer already suspended clinical trial this August… did it really not know about it,’ Hanmi Pharm announced on the 7th...
|
